$3.71
At close: Apr 2, 9:30 AM EDT
Comments
Loading...
Oxford BioMedica Analyst Ratings and Price Targets | OTC:OXBDF | Benzinga
Oxford BioMedica Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Oxford BioMedica Corp from these most-recent analyst ratings.
Analyst Ratings for Oxford BioMedica
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Oxford BioMedica (OXBDF) stock?
There is no price target for Oxford BioMedica
What is the most recent analyst rating for Oxford BioMedica (OXBDF)?
There is no analyst for Oxford BioMedica
When was the last upgrade for Oxford BioMedica (OXBDF)?
There is no last upgrade for Oxford BioMedica
When was the last downgrade for Oxford BioMedica (OXBDF)?
There is no last downgrade for Oxford BioMedica.
When is the next analyst rating going to be posted or updated for Oxford BioMedica (OXBDF)?
There is no next analyst rating for Oxford BioMedica.
Is the Analyst Rating Oxford BioMedica (OXBDF) correct?
There is no next analyst rating for Oxford BioMedica.
Browse analyst ratings and price targets on all stocks.